0001567619-21-008523.txt : 20210423 0001567619-21-008523.hdr.sgml : 20210423 20210423141505 ACCESSION NUMBER: 0001567619-21-008523 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210423 DATE AS OF CHANGE: 20210423 EFFECTIVENESS DATE: 20210423 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Genomind, Inc. CENTRAL INDEX KEY: 0001604902 IRS NUMBER: 465193717 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-382705 FILM NUMBER: 21848869 BUSINESS ADDRESS: STREET 1: 2200 RENAISSANCE BOULEVARD, SUITE 100 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406-2755 BUSINESS PHONE: 877-895-8658 MAIL ADDRESS: STREET 1: 2200 RENAISSANCE BOULEVARD, SUITE 100 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406-2755 D/A 1 primary_doc.xml X0708 D/A LIVE 0001604902 Genomind, Inc. 2200 Renaissance Boulevard, Suite 100 KING OF PRUSSIA PA PENNSYLVANIA 19406-2755 877-895-8658 DELAWARE None None Corporation true Shawn Patrick O'Brien 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 9406-2755 Executive Officer Director Mr. O'Brien is the Chief Executive Officer and the Chairman of the Board of the Issuer. Tom Hess 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 9406-2755 Executive Officer Mr. Hess is the Chief Financial Officer and Secretary of the Issuer. Stephen Haller 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Executive Officer Mr. Haller is the Treasurer of the Issuer. Beth Dozoretz 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Director John Chadwick 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 9406-2755 Director Shelloy Kiger 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 9406-2755 Director Theresa Sexton 2200 Renaissance Boulevard, Suite 100 King of Prussia PA PENNSYLVANIA 19406-2755 Director Other Health Care Decline to Disclose 06b true 0001567619-20-020791 2020-11-24 false true true true Series D Preferred Stock and Common Stock Purchase Warrants false 0 21150000 6400000 14750000 false 8 0 0 0 false Genomind, Inc. /s/ Shawn Patrick O'Brien Shawn Patrick O'Brien Chief Executive Officer of the Issuer 2021-04-22